Protein Arginine Methyltransferase 5 in T Lymphocyte Biology

Trends Immunol. 2020 Oct;41(10):918-931. doi: 10.1016/j.it.2020.08.007. Epub 2020 Sep 2.

Abstract

Protein arginine methyltransferase 5 (PRMT5) is the major methyltransferase (MT) catalyzing symmetric dimethylation (SDM). PRMT5 regulates developmental, homeostatic and disease processes in vertebrates and invertebrates, and a carcinogenic role has been observed in mammals. Recently, tools generated for PRMT5 loss of function have allowed researchers to demonstrate essential roles for PRMT5 in mouse and human lymphocyte biology. PRMT5 modulates CD4+ and CD8+ T cell development in the thymus, peripheral homeostasis, and differentiation into CD4+ helper T lymphocyte (Th)17 cell phenotypes. Here, we provide a timely review of the milestones leading to our current understanding of PRMT5 in T cell biology, discuss current tools to modify PRMT5 expression/activity, and highlight mechanistic pathways.

Keywords: PRMT5; arginine methylation; autoimmunity; lymphocytes.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cell Differentiation* / genetics
  • Humans
  • Protein-Arginine N-Methyltransferases* / immunology
  • T-Lymphocytes* / enzymology
  • T-Lymphocytes* / immunology
  • Th17 Cells* / enzymology

Substances

  • Protein-Arginine N-Methyltransferases